论文部分内容阅读
目的探讨胸外科肿瘤手术后出血进行二次手术止血的临床影响因素及治疗。方法对2006年4月至2011年11月间7511例胸部肿瘤手术患者进行了临床回顾性研究,其中16例患者术后出现活动性出血,并进行二次手术止血。结果 16例二次手术止血患者中,肺部肿瘤10例,食管肿瘤4例,纵隔肿瘤2例,无死亡病例。对肿瘤大小分析发现止血组患者肿瘤大于正常组(P<0.01)。结论活动性出血是胸外科肿瘤术后一大临床并发症,需要临床医生及时发现、准确判断和及时处理。
Objective To investigate the clinical influencing factors and treatment of hemostasis after thoracic surgery for secondary surgery. Methods From July 2006 to November 2011, 7511 patients with thoracic tumors underwent a clinical retrospective study. Among them, 16 patients had active bleeding after operation and secondary hemostasis. Results Among the 16 cases of secondary hemostasis, 10 were lung tumors, 4 esophageal tumors and 2 mediastinal tumors without any death. Tumor size analysis found that hemostasis patients had tumors larger than the normal group (P <0.01). Conclusions Active bleeding is a major clinical complication after thoracic surgery, requiring clinicians to discover, accurately judge and timely treatment.